Literature DB >> 9190936

Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex.

C S Moreno1, E M Rogers, J A Brown, J M Boss.   

Abstract

Regulatory factor X (RFX) is a transcription factor that binds the conserved X1 box of MHC class II promoters and is essential for transcription of class II genes. The subunit structure of the native RFX complex was examined by coimmunoprecipitation using polyclonal antisera to the 75-kDa subunit of RFX, RFX5. Two polypeptides with apparent masses of 41 and 36 kDa coimmunoprecipitated with RFX5 and appear to be subunits of the native RFX complex. Metabolic labeling of wild-type and mutant B cells with [32P]orthophosphate demonstrated that each of the RFX subunits was phosphorylated in vivo and that the phosphorylation of the RFX subunits was independent of the essential MHC class II regulatory factor, CIITA. The trimeric RFX complex was also present in fibroblast cells with or without IFN-gamma treatment. Both the p41 and p36 subunits were absent in immunoprecipitations of RFX5 from lysates of independently established B cell lines from bare lymphocyte syndrome complementation groups B and D. Together, these results suggest that RFX complex assembly is required for class II expression and that the mutations in bare lymphocyte syndrome complementation groups B and D result in an inability to assemble the RFX complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190936

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

Authors:  A DeSandro; U M Nagarajan; J M Boss
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 4.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  Cohesin regulates MHC class II genes through interactions with MHC class II insulators.

Authors:  Parimal Majumder; Jeremy M Boss
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

6.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.

Authors:  Alyssa Bushey Long; Jeremy M Boss
Journal:  Immunogenetics       Date:  2005-01-18       Impact factor: 2.846

8.  CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.

Authors:  Parimal Majumder; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

9.  Collagen alpha1(I) gene (COL1A1) is repressed by RFX family.

Authors:  Pritam Sengupta; Yong Xu; Lin Wang; Russell Widom; Barbara D Smith
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

10.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.